Pandion Therapeutics Inc
(PAND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 12-2019 | 12-2018 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | N/A | 15,970 | 10,172 |
| Receivables | N/A | N/A | 1,035 | 0 |
| Other current assets | 0 | 0 | 2,960 | 1,287 |
| TOTAL | $N/A | $N/A | $19,965 | $11,459 |
| Non-Current Assets | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $N/A | $N/A | $21,019 | $12,224 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 1,207 | 951 |
| Accrued Expenses | N/A | N/A | 1,455 | 1,343 |
| Other current liabilities | N/A | N/A | 4,365 | 0 |
| TOTAL | $N/A | $N/A | $7,027 | $2,294 |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | N/A | 3,676 | 2,010 |
| Other Non-Current Liabilities | 0 | 0 | 47,052 | 0 |
| TOTAL | $N/A | $N/A | $56,781 | $2,010 |
| Total Liabilities | $N/A | $N/A | $63,808 | $29,281 |
| Shareholders' Equity | ||||
| Retained earnings | N/A | N/A | -42,961 | -17,109 |
| Other shareholders' equity | 0 | 0 | 172 | 52 |
| TOTAL | $N/A | $N/A | $-42,789 | $-17,057 |
| Total Liabilities And Equity | $0 | $0 | $21,019 | $12,224 |